PMID- 36070895 OWN - NLM STAT- MEDLINE DCOM- 20221028 LR - 20221028 IS - 1349-3329 (Electronic) IS - 0040-8727 (Linking) VI - 258 IP - 3 DP - 2022 Oct 25 TI - Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma. PG - 195-206 LID - 10.1620/tjem.2022.J077 [doi] AB - Patients with esophageal squamous cell carcinoma (ESCC) might have a specific mechanism for the carcinogenesis by alcohol consumption in the background esophageal mucosa, and nuclear factor erythroid 2-related factor 2 (NRF2), which plays a protective role against esophageal carcinogenesis, and barrier dysfunction might be associated with this phenomenon. This study aimed to confirm this hypothesis. Twenty patients with superficial ESCCs (ESCC patients) and 20 age- and sex-matched patients without ESCC (non-ESCC patients) were enrolled. Biopsy samples were obtained from non-neoplastic esophageal mucosa: one for histological evaluation, one for quantitative real-time polymerase chain reaction (PCR), and two for the mini-Ussing chamber system to measure transepithelial electrical resistance (TEER) and, thereafter, for PCR. The TEER after acetaldehyde or both acetaldehyde and ethanol exposure did not differ significantly between ESCC and non-ESCC patients. Unlike non-ESCC patients, mRNA levels of NRF2 target genes and claudin4 in ESCC patients tended to decrease after the exposure, with a significant difference between no exposure and both acetaldehyde and ethanol exposure in NRF2 target genes (p < 0.05). Furthermore, in ESCC patients, the decreased tendency of mRNA levels of NRF2 target genes after the exposure was more pronounced in high-risk states, such as aldehyde dehydrogenase 2 (ALDH2) Lys alleles (Glu/Lys + Lys/Lys), Lugol-voiding lesion grade C, and drinking history. In conclusion, the protective role of NRF2 against carcinogenesis from alcohol exposure might be disrupted in the background esophageal mucosa of ESCC patients, which might lead to a high incidence of metachronous ESCC. FAU - Toda, Shusuke AU - Toda S AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Hatta, Waku AU - Hatta W AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Asanuma, Kiyotaka AU - Asanuma K AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Asano, Naoki AU - Asano N AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Ono, Yoshitaka AU - Ono Y AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Abe, Hiroko AU - Abe H AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Ogata, Yohei AU - Ogata Y AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Saito, Masahiro AU - Saito M AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Kanno, Takeshi AU - Kanno T AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Jin, Xiaoyi AU - Jin X AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Uno, Kaname AU - Uno K AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Koike, Tomoyuki AU - Koike T AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Imatani, Akira AU - Imatani A AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Hamada, Shin AU - Hamada S AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. FAU - Nakamura, Tomohiro AU - Nakamura T AD - Department of Health Record Informatics, Tohoku Medical Megabank Organization, Tohoku University. FAU - Nakaya, Naoki AU - Nakaya N AD - Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University. FAU - Masamune, Atsushi AU - Masamune A AD - Division of Gastroenterology, Tohoku University Graduate School of Medicine. LA - eng PT - Journal Article DEP - 20220908 PL - Japan TA - Tohoku J Exp Med JT - The Tohoku journal of experimental medicine JID - 0417355 RN - EC 1.2.1.3 (Aldehyde Dehydrogenase, Mitochondrial) RN - 0 (NF-E2-Related Factor 2) RN - 0 (Claudin-4) RN - 3K9958V90M (Ethanol) RN - GO1N1ZPR3B (Acetaldehyde) RN - 0 (RNA, Messenger) RN - EC 1.2.1.3 (ALDH2 protein, human) SB - IM MH - Humans MH - *Esophageal Squamous Cell Carcinoma/genetics MH - Esophageal Mucosa/metabolism/pathology MH - *Esophageal Neoplasms/genetics/pathology MH - Aldehyde Dehydrogenase, Mitochondrial/genetics MH - *Carcinoma, Squamous Cell/pathology MH - NF-E2-Related Factor 2/genetics MH - Claudin-4 MH - Risk Factors MH - Ethanol MH - Acetaldehyde/metabolism MH - Carcinogenesis MH - RNA, Messenger OTO - NOTNLM OT - NRF2 target genes OT - acetaldehyde OT - esophageal mucosa OT - esophageal squamous cell carcinoma OT - ethanol EDAT- 2022/09/08 06:00 MHDA- 2022/10/29 06:00 CRDT- 2022/09/07 21:23 PHST- 2022/09/08 06:00 [pubmed] PHST- 2022/10/29 06:00 [medline] PHST- 2022/09/07 21:23 [entrez] AID - 10.1620/tjem.2022.J077 [doi] PST - ppublish SO - Tohoku J Exp Med. 2022 Oct 25;258(3):195-206. doi: 10.1620/tjem.2022.J077. Epub 2022 Sep 8.